Adrian F. Hernandez
Duke University
1021 Papers
3.7K Citations
Adrian F. Hernandez is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 100, co-authored 849 publications. Previous affiliations of Adrian F. Hernandez include University of Mississippi Medical Center & Cleveland Clinic.
Chat about Author
Papers
Clinical and echocardiographic diversity associated with physical fitness in the Project Baseline Health Study: implications for heart failure staging.
Nicholas Cauwenberghs,François Haddad,Melissa A. Daubert,Ranee Chatterjee,Michael Salerno,Jessica L. Mega,Paul A. Heidenreich,Adrian F. Hernandez,Myriam Amsallem,Yukari Kobayashi,Kenneth W. Mahaffey,Svati H. Shah,Gerald S. Bloomfield,Tatiana Kuznetsova,Pamela S. Douglas +14 more
TL;DR: In this article , the authors determined heterogeneity in clinical and echocardiographic phenotypes and its association with exercise capacity and found that the presence of these features may carry diverse information about the development of heart failure.
5
Dysphagia in the setting of left ventricular assist device hemolysis.
Robert J. Mentz,Kelly Schlendorf,Adrian F. Hernandez,Carmelo A. Milano,G. Michael Felker,Laura J. Blue,Jacob N. Schroder,Joseph G. Rogers,Chetan B. Patel +8 more
TL;DR: A 69-year-old man with advanced heart failure treated with a continuous-flow left ventricular assist device presented for evaluation of dark urine and severe dysphagia and had progressive end-organ dysfunction and was therefore treated with tissue plasminogen activator with prompt resolution in hemolysis and dysphagía.
Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
TL;DR: Attention towards vasodilators and natriuretic peptides, such as nesiritide, has increased owing to nesSpiritide’s symptomatic improvement and unique mechanism of improvement in hemodynamics.
5
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure.
Lesley H. Curtis,Xiaojuan Mi,Laura G. Qualls,Bradley G. Hammill,Stephen C. Hammill,Paul A. Heidenreich,Frederick A. Masoudi,Soko Setoguchi,Adrian F. Hernandez,Gregg C. Fonarow +9 more
TL;DR: Evaluating the clinical effectiveness of aldosterone antagonist therapy in Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction with underrepresented population in clinical trials has the potential to inform clinical decision making and improve patient outcomes.
5